AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15118486
Drug: Donepezil (acetylcholinesterase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil (acetylcholinesterase inhibitor)
Trial: 11777514
Drug: Propofol 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 0.5 mg/kg per hour
Trial: 11777514
Drug: Propofol 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 1.0 mg/kg per hour
Trial: 11777514
Drug: Propofol 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 2.0 mg/kg per hour
Trial: 7627338
Drug: Intramuscular hMG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular hMG at a daily dose of 150 IU in combination with buserelin
Trial: 7627338
Drug: Pulsatile intravenous
RxNorm normalized name: PULSATILLA PRATENSIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsatile intravenous hMG at a daily dose of 112.5 IU in combination with buserelin
Trial: 2039326
Drug: One-dose cefazolin
RxNorm normalized name: Next Choice One Dose
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: One-dose cefazolin
Trial: 2039326
Drug: Six-dose cefazolin
RxNorm normalized name: Cefazolin
DrugBank: Cefazolin (DB01327)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Six-dose cefazolin
Trial: 20127230
Drug: Oral cladribine
RxNorm normalized name: Cladribine
DrugBank: Cladribine (DB00242)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral cladribine
Trial: 12377315
Drug: High-dose fractionated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose fractionated preoperative radiotherapy (5 x 5 Gy)
Trial: 11122794
Drug: Dose-intensive chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose-intensive chemotherapy
Trial: 11122794
Drug: Conventional dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional dose therapy
Trial: 7572019
Drug: Polygeline 35
RxNorm normalized name: polygeline 35 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polygeline 35 mg.ml‐1 (Haemaccel)
Trial: 7572019
Drug: Dextran 70
RxNorm normalized name: Dextran 70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextran 70 (Macrodex) 60 mg.ml‐1
Trial: 7572019
Drug: Albumin 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albumin 40 mg.ml‐1 in saline
Trial: 7000227
Drug: Prophylactic metronidazole
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prophylactic metronidazole (1-g suppository with premedication and 200 mg t.d.s. orally for 7 days)
Trial: 28087506
Drug: Ustekinumab 90
RxNorm normalized name: ustekinumab 90 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ustekinumab 90 mg at weeks 0, 4 and every 8 weeks
Trial: 28087506
Drug: Guselkumab 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guselkumab 50 mg at weeks 0, 4 and every 8 weeks
Trial: 28087506
Drug: Guselkumab 200
RxNorm normalized name: guselkumab 200 MG in 20 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guselkumab 200 mg at weeks 0, 4 and every 8 weeks
Trial: 21161742
Drug: Intraarticular injection
RxNorm normalized name: dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intraarticular injection of an IL‐1 inhibitor
Trial: 19067085
Drug: Culturally tailored
RxNorm normalized name: casein, emmental cultured
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Culturally tailored navigator program including educational material, phone or in-person contact by language-concordant navigators, patient education, procedure scheduling, translation of bowel preparation, and assistance with transportation and insurance coverage.
Trial: 15996033
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose H(2)RAs
Trial: 15996033
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose proton pump inhibitors
Trial: 15996033
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose other proton pump inhibitors
Trial: 15996033
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose omeprazole
Trial: 1907907
Drug: Gabapentin 1,200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 1,200 mg/day
Trial: 7066137
Drug: Etomidate (0.1-0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etomidate (0.1-0.4 mg kg‐1)
Trial: 7066137
Drug: Additional injections
RxNorm normalized name: chromous chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Additional injections of etomidate
Trial: 7066137
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of etomidate
Trial: 31838148
Drug: Moderate training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate training group (MG)
Trial: 30597719
Drug: Medtronic SCS
RxNorm normalized name: SC 41930
DrugBank: SC 41930 (DB17101)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medtronic SCS device (primo-implant)
Trial: 30597719
Drug: Medtronic SCS
RxNorm normalized name: SC 41930
DrugBank: SC 41930 (DB17101)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medtronic SCS device (replacement implant)
Trial: 22775239
Drug: ABT-102 6
RxNorm normalized name: ABT-925
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT-102 6 mg
Trial: 22775239
Drug: ABT-102 2
RxNorm normalized name: ABT-925
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT-102 2 mg
Trial: 22775239
Drug: ABT-102 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT-102 0.5 mg
Trial: 15006580
Drug: Surgery and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgery and adjuvant chemotherapy (9 cycles of 5 days every 4 weeks; daily administration of 200 mg/m² folinic acid, 5-fluorouracil starting at 375 mg/m² increasing to 500 mg/m², and CDDP 15 mg/m²)
Trial: 11732150
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A fortified biscuits with de-worming treatment
Trial: 11732150
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A fortified biscuits without de-worming treatment
Trial: 11732150
Drug: Antihelminthic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihelminthic treatment
Trial: 9219700
Drug: Prednisone (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (0.5 to 0.8 mg/kg/day) and aspirin (100 mg/day)
Trial: 9219700
Drug: Prednisone and
RxNorm normalized name: chloroprednisone and antiinfectives
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone and aspirin
Trial: 8195582
Drug: Amitriptyline 115
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline 115 mg/day
Trial: 8195582
Drug: Alprazolam 3.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam 3.2 mg/day
Trial: 3591728
Drug: Zinc-histidine (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc-histidine (15 mg)
Trial: 3591728
Drug: Zinc preparations
RxNorm normalized name: zinc preparations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc preparations (both zinc-histidine and zinc sulfate)
Trial: 27665195
Drug: Hypofractionated treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypofractionated treatment
Trial: 27665195
Drug: Hypofractionated treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypofractionated treatment vs Conventional treatment
Trial: 24964505
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin K antagonists (VKAs)
Trial: 20026501
Drug: 6 weeks
RxNorm normalized name: perampanel
DrugBank: Perampanel (DB08883)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 6 weeks of abduction treatment
Trial: 20026501
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (treatment and surveillance)
Trial: 18164001
Drug: Monophasic oral
RxNorm normalized name: hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Tablet [Urelle]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monophasic oral contraceptive pill (ethinylestradiol plus norethisterone)
Trial: 1348168
Drug: 0 mg/70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg/70 kg dezocine
Trial: 1348168
Drug: 2.5 mg/70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg/70 kg dezocine
Trial: 1348168
Drug: 5.0 mg/70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5.0 mg/70 kg dezocine
Trial: 1348168
Drug: 10 mg/70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/70 kg dezocine
Trial: 27126971
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate (CC) 100 mg/day for 5 days, started the next day after finishing medroxyprogesterone acetate course (early induction)
Trial: 27126971
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate (CC) 100 mg/day for 5 days, started on day 2 of withdrawal bleeding (late induction)
Trial: 23038702
Drug: Curcumin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin (1 g/d, n = 46)
Trial: 19301936
Drug: niacin extended-release
RxNorm normalized name: Niacin Extended-Release Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: niacin extended-release (NER) 500 mg/day in week 1, 1000 mg/day in week 2, and 2000 mg/day in weeks 3-6/aspirin (ASA)
Trial: 17493057
Drug: Pre-treatment methamphetamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-treatment methamphetamine use
Trial: 17493057
Drug: Gender, route
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gender, route of administration, and pre-treatment methamphetamine use
Trial: 9722054
Drug: butorphanol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: butorphanol (2 mg) + bupivacaine (0.25%)
Trial: 8051795
Drug: L-627 (biapenem)
RxNorm normalized name: L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-627 (biapenem) 6 mg/kg
Trial: 8051795
Drug: L-627 (biapenem)
RxNorm normalized name: L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-627 (biapenem) 12 mg/kg
Trial: 8051795
Drug: L-627 (biapenem)
RxNorm normalized name: L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-627 (biapenem) 5 mg/kg
Trial: 8051795
Drug: L-627 (biapenem)
RxNorm normalized name: L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-627 (biapenem) 20-40 mg/kg
Trial: 7933528
Drug: L-627 (biapenem)
RxNorm normalized name: L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-627 (biapenem)
Trial: 2923084
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg all‐rac‐alpha‐tocopherol and RRR‐gamma‐tocopherol
Trial: 28532478
Drug: 40ml High
RxNorm normalized name: HIGH DENSITY POLYETHYLENE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40ml High Volume Image Guided Injection (HVIGI) with or without corticosteroid
Trial: 28532478
Drug: 3ml local
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 3ml local anaesthetic sham-control injection
Trial: 19732281
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate (154 mEq/L)
Trial: 19732281
Drug: Sodium chloride
RxNorm normalized name: Sodium Chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium chloride (0.9%) and oral N-acetylcysteine (NAC)
Trial: 22905595
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment with high-dose hypoallergenic 6-grass pollen preparation (SCIT)
Trial: 12451325
Drug: Verapamil 180
RxNorm normalized name: verapamil 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil 180 mg/day + Trandolapril 2 mg/day
Trial: 12451325
Drug: Atenolol 50
RxNorm normalized name: atenolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 50 mg/day + Nifedipine 20 mg/day
Trial: 2172178
Drug: Dietary fibre
RxNorm normalized name: Fiore
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary fibre supplement (7 g/day)
Trial: 30477789
Drug: Telotristat ethyl
RxNorm normalized name: Telotristat ethyl
DrugBank: Telotristat ethyl (DB12095)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Telotristat ethyl (TE) 250 mg TID
Trial: 30477789
Drug: Telotristat ethyl
RxNorm normalized name: Telotristat ethyl
DrugBank: Telotristat ethyl (DB12095)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Telotristat ethyl (TE) 500 mg TID
Trial: 30477789
Drug: Telotristat ethyl
RxNorm normalized name: Telotristat ethyl
DrugBank: Telotristat ethyl (DB12095)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Telotristat ethyl (TE) 500 mg TID in open-label extension (OLE)
Trial: 25701700
Drug: 4.375 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.375 g/day gluten
Trial: 20575400
Drug: Sanjin pills,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sanjin pills, 3 pills 3 times a day for 7 days
Trial: 19090322
Drug: APD125 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: APD125 10 mg
Trial: 19090322
Drug: APD125 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: APD125 40 mg
Trial: 15980934
Drug: Paracetamol 1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol 1500 mg/day for 2 months
Trial: 15324466
Drug: Albendazole (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albendazole (400 mg) alone
Trial: 1893709
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive use before pregnancy
Trial: 1893709
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive use in early pregnancy
Trial: 7049588
Drug: Proglumetacin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proglumetacin (300 mg daily in two divided doses)
Trial: 7049588
Drug: Naproxen (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen (500 mg daily in two divided doses)
Trial: 29470389
Drug: Walnut-enriched diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Walnut-enriched diet (43 g/day)
Trial: 12436013
Drug: Psychoeducational Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychoeducational Therapy (PET)
Trial: 12029990
Drug: Pravastatin (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (low dose, 5 mg/day)
Trial: 12029990
Drug: Simvastatin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (5 to 10 mg/day for 6 years)
Trial: 2693916
Drug: Oestrogen-progestogen replacement
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oestrogen-progestogen replacement therapy for 12 months
Trial: 447801
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (100 mg)
Trial: 447801
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (400 mg)
Trial: 31591706
Drug: Single injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single injection of PPD (n=29)
Trial: 31591706
Drug: Multiple injections
RxNorm normalized name: sodium acetate
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multiple injections of PPD (n=29)
Trial: 19487505
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment (standard decompressive laminectomy with or without fusion)
Trial: 15482766
Drug: Transdermal E(2)
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal E(2) 50 microg/24 hours
Trial: 15482766
Drug: Transdermal E(2)
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal E(2) 75 microg/24 hours
Trial: 15482766
Drug: Transdermal E(2)
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal E(2) 100 microg/24 hours
Trial: 7815840
Drug: ATRA (all-trans
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ATRA (all-trans retinoic acid) treatment
Trial: 2455141
Drug: Nifedipine as
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine as a capsule with high sodium intake
Trial: 2455141
Drug: Nifedipine as
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine as a tablet with high sodium intake
Trial: 2455141
Drug: Nifedipine with
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine with addition of a thiazide diuretic for 1 month
Trial: 29866147
Drug: Actitan F
RxNorm normalized name: Stomodine F
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Actitan F and standard oral rehydration (SOR)
Trial: 29866147
Drug: Standard oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard oral rehydration (SOR) only
Trial: 22561556
Drug: Lactobacillus reuteri
RxNorm normalized name: Lactobacillus reuteri
DrugBank: Lactobacillus reuteri (DB14224)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus reuteri NCIMB 30242 capsules (n=67)
Trial: 22561556
Drug: Placebo capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo capsules (n=64)
Trial: 20054544
Drug: Paracetamol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol (1 g as a 100 ml solution infused over 15 min, 1 h before anesthesia induction and then at 6-h intervals for 24 h)
Trial: 20054544
Drug: Paracetamol and
RxNorm normalized name: Paracetamol and tramadol only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol and Placebo
Trial: 11004028
Drug: Clonidine (2.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (2.25 ng/mL) in awake subjects
Trial: 11004028
Drug: Clonidine (2.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (2.25 ng/mL) in anesthetized subjects
Trial: 1609533
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg Tramadol (Tramal)
Trial: 1609533
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg Tramadol (Tramal) and 10 mg Triflupromazine (Psyquil)
Trial: 1609533
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg Pethidine (Alodan) and 10 mg Triflupromazine (Psyquil)
Trial: 1609533
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of analgesic with antiemetic
Trial: 6375285
Drug: Oral pretreatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral pretreatment with verapamil for one week
Trial: 6375285
Drug: 3-hour iv
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-hour iv infusion of verapamil
Trial: 6375285
Drug: Oral glibenclamide
RxNorm normalized name: glibenclamide
DrugBank: Glyburide (DB01016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral glibenclamide therapy
Trial: 6375285
Drug: iv infusion
RxNorm normalized name: IV INFUSION SET (WINTHROP)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iv infusion of verapamil
Trial: 3550149
Drug: Intracavernous self-injection
RxNorm normalized name: bivalirudin
DrugBank: Bivalirudin (DB00006)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracavernous self-injection of phentolamine and papaverine
Trial: 23635012
Drug: Reduction of
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reduction of dialysate sodium concentration from 138 to 135 mEq/L (Group A)
Trial: 18482012
Drug: Onion extract
RxNorm normalized name: Onion Extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Onion extract gel treatment
Trial: 17058225
Drug: Tenofovir disoproxil
RxNorm normalized name: Tenofovir Disoproxil
DrugBank: Tenofovir disoproxil (DB00300)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tenofovir disoproxil fumarate (TDF) 300 mg daily
Trial: 12221213
Drug: Enzymatically hydrolyzed
RxNorm normalized name: hydrolyzed sericin (enzymatic; 2500 MW)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enzymatically hydrolyzed isoflavone drink (1 mg total isoflavones/kg body)
Trial: 12221213
Drug: Non-hydrolyzed isoflavone
RxNorm normalized name: collagen, hydrolyzed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-hydrolyzed isoflavone drink (1 mg total isoflavones/kg body)
Trial: 7620688
Drug: Transdermal nitroglycerin
RxNorm normalized name: nitroglycerin Transdermal System
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal nitroglycerin 5 mg/24 hours for 2 weeks, titrated to 10 mg/24 hours for 4 weeks if needed
Trial: 7620688
Drug: Oral nitrates
RxNorm normalized name: Nitrate
DrugBank: Nitrate (DB14049)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral nitrates (previous treatment)
Trial: 7620688
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (previous treatment with oral nitrates)